Metsera
New York, NY · Founded 2022 · CIK 0002040807 · Biotech · Private
Long-acting injectable GLP-1 receptor agonist
metsera.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $215M
- 1 Form D · Nov 2024
- 23 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $214,999,939 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2788 | Avalyn Pharma | — | $242M |
| 2789 | Zylo Therapeutics Inc. | — | $4.9M |
| 2790 | Arbor Biotechnologies | — | $227M |
| 2791 | Metsera | — | $215M |
| 2792 | Affinivax, Inc. | — | $233M |
| 2793 | Forge Biologics Holdings, LLC | — | $160M |
| 2794 | Empress Therapeutics | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Christopher BernardDirector · Executive Officer
- Paul BernsDirector
- Kristina BurowDirector
- Brian HubbardExecutive Officer
- Steven MarsoExecutive Officer
- Clive MeanwellDirector
- Joshua PintoDirector
- Christopher VisioliExecutive Officer
Patents
- Oral Peptides And Uses Thereof For Weight Loss, Weight Maintenance, And Management Of Metabolic Conditionsapplication
- GLP-1 Receptor Agonist Compositions And Methods Of Use Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.